-
Je něco špatně v tomto záznamu ?
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
S. Syrbe, UB. Hedrich, E. Riesch, T. Djémié, S. Müller, RS. Møller, B. Maher, L. Hernandez-Hernandez, M. Synofzik, HS. Caglayan, M. Arslan, JM. Serratosa, M. Nothnagel, P. May, R. Krause, H. Löffler, K. Detert, T. Dorn, H. Vogt, G. Krämer, L....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu kazuistiky, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1998-06-01 do 2015-11-30
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
PubMed
25751627
DOI
10.1038/ng.3239
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- dospělí MeSH
- draslíkový kanál Kv1.2 genetika MeSH
- epilepsie genetika MeSH
- genetická predispozice k nemoci MeSH
- kohortové studie MeSH
- kojenec MeSH
- křeče u dětí genetika MeSH
- lidé MeSH
- mladý dospělý MeSH
- mutace * MeSH
- předškolní dítě MeSH
- rodokmen MeSH
- sekvence aminokyselin MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Epileptic encephalopathies are a phenotypically and genetically heterogeneous group of severe epilepsies accompanied by intellectual disability and other neurodevelopmental features. Using next-generation sequencing, we identified four different de novo mutations in KCNA2, encoding the potassium channel KV1.2, in six isolated patients with epileptic encephalopathy (one mutation recurred three times independently). Four individuals presented with febrile and multiple afebrile, often focal seizure types, multifocal epileptiform discharges strongly activated by sleep, mild to moderate intellectual disability, delayed speech development and sometimes ataxia. Functional studies of the two mutations associated with this phenotype showed almost complete loss of function with a dominant-negative effect. Two further individuals presented with a different and more severe epileptic encephalopathy phenotype. They carried mutations inducing a drastic gain-of-function effect leading to permanently open channels. These results establish KCNA2 as a new gene involved in human neurodevelopmental disorders through two different mechanisms, predicting either hyperexcitability or electrical silencing of KV1.2-expressing neurons.
Center for Genomics and Transcriptomics Tübingen Germany
Child and Adolescent Department Pediatric Neurology University Hospitals Geneva Switzerland
Cologne Center for Genomics University of Cologne Cologne Germany
Department of Medical Genetics Institute of Mother and Child Warsaw Poland
Department of Molecular Biology and Genetics Bo[gcaron]aziçi University Istanbul Turkey
Department of Neuropediatrics University of Tübingen Tübingen Germany
Division of Child Neurology Gulhane Military Medical School Ankara Turkey
Division of Human Genetics University Children's Hospital Inselspital Bern Switzerland
Division of Neuropediatrics University Children's Hospital Inselspital Bern Switzerland
Division of Pediatric Endocrinology University Children's Hospital Inselspital Bern Switzerland
Luxembourg Centre for Systems Biomedicine University of Luxembourg Esch sur Alzette Luxembourg
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022794
- 003
- CZ-PrNML
- 005
- 20150727123727.0
- 007
- ta
- 008
- 150709s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/ng.3239 $2 doi
- 035 __
- $a (PubMed)25751627
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Syrbe, Steffen $u Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
- 245 10
- $a De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy / $c S. Syrbe, UB. Hedrich, E. Riesch, T. Djémié, S. Müller, RS. Møller, B. Maher, L. Hernandez-Hernandez, M. Synofzik, HS. Caglayan, M. Arslan, JM. Serratosa, M. Nothnagel, P. May, R. Krause, H. Löffler, K. Detert, T. Dorn, H. Vogt, G. Krämer, L. Schöls, PE. Mullis, T. Linnankivi, AE. Lehesjoki, K. Sterbova, DC. Craiu, D. Hoffman-Zacharska, CM. Korff, YG. Weber, M. Steinlin, S. Gallati, A. Bertsche, MK. Bernhard, A. Merkenschlager, W. Kiess, . , M. Gonzalez, S. Züchner, A. Palotie, A. Suls, P. De Jonghe, I. Helbig, S. Biskup, M. Wolff, S. Maljevic, R. Schüle, SM. Sisodiya, S. Weckhuysen, H. Lerche, JR. Lemke,
- 520 9_
- $a Epileptic encephalopathies are a phenotypically and genetically heterogeneous group of severe epilepsies accompanied by intellectual disability and other neurodevelopmental features. Using next-generation sequencing, we identified four different de novo mutations in KCNA2, encoding the potassium channel KV1.2, in six isolated patients with epileptic encephalopathy (one mutation recurred three times independently). Four individuals presented with febrile and multiple afebrile, often focal seizure types, multifocal epileptiform discharges strongly activated by sleep, mild to moderate intellectual disability, delayed speech development and sometimes ataxia. Functional studies of the two mutations associated with this phenotype showed almost complete loss of function with a dominant-negative effect. Two further individuals presented with a different and more severe epileptic encephalopathy phenotype. They carried mutations inducing a drastic gain-of-function effect leading to permanently open channels. These results establish KCNA2 as a new gene involved in human neurodevelopmental disorders through two different mechanisms, predicting either hyperexcitability or electrical silencing of KV1.2-expressing neurons.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a epilepsie $x genetika $7 D004827
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a draslíkový kanál Kv1.2 $x genetika $7 D051663
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a křeče u dětí $x genetika $7 D013036
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hedrich, Ulrike B S $u Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Riesch, Erik $u 1] Center for Genomics and Transcriptomics (CeGaT), Tübingen, Germany. [2] Division of Human Genetics, University Children's Hospital Inselspital, Bern, Switzerland. [3] Swiss Epilepsy Center, Zürich, Switzerland.
- 700 1_
- $a Djémié, Tania $u 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a Müller, Stephan $u Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Møller, Rikke S $u 1] Danish Epilepsy Center, Dianalund, Denmark. [2] Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark.
- 700 1_
- $a Maher, Bridget $u 1] Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, Queen Square, London, UK. [2] Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
- 700 1_
- $a Hernandez-Hernandez, Laura $u 1] Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, Queen Square, London, UK. [2] Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
- 700 1_
- $a Synofzik, Matthis $u 1] Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. [2] German Research Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
- 700 1_
- $a Caglayan, Hande S $u Department of Molecular Biology and Genetics, Bo[gcaron]aziçi University, Istanbul, Turkey.
- 700 1_
- $a Arslan, Mutluay $u Division of Child Neurology, Gulhane Military Medical School, Ankara, Turkey. $7 gn_A_00008972
- 700 1_
- $a Serratosa, José M $u 1] Neurology Laboratory and Epilepsy Unit, Department of Neurology, Instituto de Investigatión Sanitaria-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain. [2] Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
- 700 1_
- $a Nothnagel, Michael $u Cologne Center for Genomics, University of Cologne, Cologne, Germany.
- 700 1_
- $a May, Patrick $u Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- 700 1_
- $a Krause, Roland $u Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- 700 1_
- $a Löffler, Heidrun $u Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Detert, Katja $u Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Dorn, Thomas $u Swiss Epilepsy Center, Zürich, Switzerland.
- 700 1_
- $a Vogt, Heinrich $u Swiss Epilepsy Center, Zürich, Switzerland.
- 700 1_
- $a Krämer, Günter $u Swiss Epilepsy Center, Zürich, Switzerland.
- 700 1_
- $a Schöls, Ludger $u 1] Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. [2] German Research Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
- 700 1_
- $a Mullis, Primus E $u Division of Pediatric Endocrinology, University Children's Hospital Inselspital, Bern, Switzerland.
- 700 1_
- $a Linnankivi, Tarja $u Department of Pediatric Neurology, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- 700 1_
- $a Lehesjoki, Anna-Elina $u 1] Folkhälsan Institute of Genetics, Helsinki, Finland. [2] Neuroscience Center, University of Helsinki, Helsinki, Finland. [3] Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.
- 700 1_
- $a Sterbova, Katalin $u Department of Child Neurology, 2nd Faculty of Medicine, Charles University, Motol Hospital, Prague, Czech Republic.
- 700 1_
- $a Craiu, Dana C $u 1] Pediatric Neurology Clinic II, Department of Neurology, Pediatric Neurology, Psychiatry and Neurosurgery, 'Carol Davila' University of Medicine, Bucharest, Romania. [2] Pediatric Neurology Clinic, 'Professor Doctor Alexandru Obregia' Clinical Hospital, Bucharest, Romania.
- 700 1_
- $a Hoffman-Zacharska, Dorota $u Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
- 700 1_
- $a Korff, Christian M $u Child and Adolescent Department, Pediatric Neurology, University Hospitals, Geneva, Switzerland.
- 700 1_
- $a Weber, Yvonne G $u Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Steinlin, Maja $u Division of Neuropediatrics, University Children's Hospital Inselspital, Bern, Switzerland.
- 700 1_
- $a Gallati, Sabina $u Division of Human Genetics, University Children's Hospital Inselspital, Bern, Switzerland.
- 700 1_
- $a Bertsche, Astrid $u Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a Bernhard, Matthias K $u Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a Merkenschlager, Andreas $u Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a Kiess, Wieland $u Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a ,
- 700 1_
- $a Gonzalez, Michael $u Dr. J.T. MacDonald Department for Human Genetics, Hussman Institute for Human Genomics, University of Miami, Miami, Florida, USA.
- 700 1_
- $a Züchner, Stephan $u Dr. J.T. MacDonald Department for Human Genetics, Hussman Institute for Human Genomics, University of Miami, Miami, Florida, USA.
- 700 1_
- $a Palotie, Aarno $u 1] Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. [2] Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. [3] Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
- 700 1_
- $a Suls, Arvid $u 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a De Jonghe, Peter $u 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. [3] Department of Neurology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a Helbig, Ingo $u 1] Department of Neuropediatrics, Christian Albrechts University of Kiel, Kiel, Germany. [2] Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- 700 1_
- $a Biskup, Saskia $u Center for Genomics and Transcriptomics (CeGaT), Tübingen, Germany.
- 700 1_
- $a Wolff, Markus $u Department of Neuropediatrics, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Maljevic, Snezana $u Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Schüle, Rebecca $u 1] Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. [2] German Research Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. [3] Dr. J.T. MacDonald Department for Human Genetics, Hussman Institute for Human Genomics, University of Miami, Miami, Florida, USA.
- 700 1_
- $a Sisodiya, Sanjay M $u 1] Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, Queen Square, London, UK. [2] Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
- 700 1_
- $a Weckhuysen, Sarah $u 1] Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. [2] Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a Lerche, Holger $u 1] Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. [2] Department of Neurology, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Lemke, Johannes R $u 1] Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany. [2] Division of Human Genetics, University Children's Hospital Inselspital, Bern, Switzerland. [3] Institute of Human Genetics, University of Leipzig, Leipzig, Germany.
- 773 0_
- $w MED00003458 $t Nature genetics $x 1546-1718 $g Roč. 47, č. 4 (2015), s. 393-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25751627 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150727123811 $b ABA008
- 999 __
- $a ok $b bmc $g 1083133 $s 905787
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 47 $c 4 $d 393-9 $i 1546-1718 $m Nature genetics $n Nat Genet $x MED00003458
- LZP __
- $a Pubmed-20150709